SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem - Quaterly Results

20 Oct 2022 Evaluate
The turnover zoomed to Rs. 5555.30 millions, up 63.57% for the September 2022 quarter as against Rs. 3396.26 millions during the year-ago period.Net profit for the quarter ended September 2022 increased significantly by 94.79% to Rs. 915.69 millions from Rs. 470.08 millions.Operating Profit saw a handsome growth to 1819.70 millions from 1027.94 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 5555.30 3396.26 63.57 10883.80 6299.71 72.77 15509.41 8286.00 87.18
Other Income 16.76 22.63 -25.94 37.06 24.36 52.13 41.11 21.89 87.80
PBIDT 1819.70 1027.94 77.02 3714.63 1954.50 90.06 5135.97 2635.17 94.90
Interest 143.61 97.23 47.70 254.83 220.99 15.31 442.70 291.14 52.06
PBDT 1676.09 930.71 80.09 3459.80 1733.51 99.58 4693.27 2344.03 100.22
Depreciation 259.46 217.30 19.40 479.85 430.27 11.52 859.06 735.45 16.81
PBT 1416.63 713.41 98.57 2979.95 1303.24 128.66 3834.21 1608.58 138.36
TAX 500.94 243.33 105.87 986.34 463.60 112.76 1306.36 600.19 117.66
Deferred Tax 246.02 106.60 130.79 450.95 223.93 101.38 609.63 318.51 91.40
PAT 915.69 470.08 94.79 1993.61 839.64 137.44 2527.85 1008.39 150.68
Equity 415.50 415.50 0.00 415.50 415.53 -0.01 415.50 415.53 -0.01
PBIDTM(%) 32.76 30.27 8.22 34.13 31.03 10.01 33.12 31.80 4.13

Epigral Share Price

1327.55 -44.20 (-3.22%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4035.90
Tata Chemicals 782.10
SRF 2780.75
Pidilite Inds. 1476.15
Deepak Nitrite 1875.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×